Stay updated with breaking news from Material Adverse Event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
$46.4 million cash and investments on hand sufficient to fund current operations, including multiple value driving milestones, through the end of 2025Topline efficacy data for VenoValve® U.S. pivotal trial to be presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024Continued progress towar...
EnVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial ...
Share Subscription Agreement in connection with CHINA EVERGRANDE NEW ENERGY VEHICLE GROUP LIMITED among CHINA EVERGRANDE NEW... -Today at 09:31 am- MarketScreener
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twitter, Inc. ("Twitter" or the...
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twitter, Inc. ("Twitter" or the...